Distinguishing the progression of an endometrioma: Benign or malignant?

---

Atıf İçin Kopyala

BAŞTU E., Onder S., Demiral I., Ozsurmeli M., Keskin G., TAKMAZ Ö., ...Daha Fazla

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.230, ss.79-84, 2018 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 230
• Basım Tarihi: 2018
• Doi Numarası: 10.1016/j.ejogrb.2018.09.026
• Dergi Adı: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.79-84
• İstanbul Üniversitesi Adresli: Evet

Özet

Objective: To elucidate the immunohistochemical (IHC) differences of endometrioma tissues that may have the potential to progress to ovarian clear cell carcinoma (OCCC) by using KRAS, HNF1 beta, PIK3CA, PPP2R1A, and ARID1A as biomarkers.